Elucid
Clinically validated medical-imaging software that analyzes CT angiography to characterize arterial plaque and help clinicians assess cardiovascular risk.
$55MSeries D
Role not disclosedUs
Undisclosed strategic investor
Activity from announced rounds
Activity in this selectionluxin-venture-capital-099dad23
- Rounds participated in
- 1
- Confirmed lead rounds
- — 1 roles undisclosed
- New companies
- 1 First participation on record · 0 follow-on
- Funding in participating rounds
- $55M 1 disclosed · full round size, not this investor’s share